Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
Dalton T, Doubrovina E, Pankov D, Reynolds R, Scholze H, Selvakumar A, Vizconde T, Savalia B, Dyomin V, Weigel C, Oakes CC, Alonso A, Elemento O, Pan H, Phillip JM, O'Reilly RJ, Gewurz BE, Cesarman E, Giulino-Roth L.
Dalton T, et al. Among authors: dyomin v.
Blood. 2020 May 21;135(21):1870-1881. doi: 10.1182/blood.2019004126.
Blood. 2020.
PMID: 32157281
Free PMC article.